How to prepare a patient with pheochromocytoma for surgery?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Preoperative Management of Pheochromocytoma for Surgery

All patients with pheochromocytoma should receive preoperative alpha-adrenergic blockade for at least 10-14 days before surgery to prevent hypertensive crises and arrhythmias during the procedure. 1

Alpha-Adrenergic Blockade Protocol

  • Begin alpha-adrenergic blockade at least 10-14 days before surgery with gradual dose escalation until blood pressure targets are achieved 1, 2
  • Blood pressure targets: <130/80 mmHg in supine position and systolic blood pressure >90 mmHg in upright position 1, 2
  • Alpha-blocker options:
    • Phenoxybenzamine (non-selective, non-competitive α1 and α2 blocker): Start with 10 mg twice daily and adjust every 2-4 days 1, 3
    • Doxazosin, prazosin, or terazosin (selective α1 blockers): May be as effective with fewer side effects 1, 2
    • Phenoxybenzamine may provide less intraoperative hemodynamic instability compared to selective blockers 1, 2

Additional Preoperative Measures

  • Add beta-blockers ONLY after adequate alpha blockade is established to control tachyarrhythmias 1, 2
    • Never start beta-blockers before alpha-blockers as this can precipitate hypertensive crisis 1, 2, 4
  • Consider calcium channel blockers (nifedipine slow release) or metyrosine if target blood pressure is not reached with alpha blockade 1, 2
    • Metyrosine inhibits catecholamine synthesis and may improve intraoperative blood pressure control and reduce blood loss when combined with alpha-blockers 5, 6
  • Implement high-sodium diet and administer 1-2 liters of saline 24 hours before surgery to prevent postoperative hypotension 2
  • Use compressive stockings to reduce orthostatic hypotension risk 2

Intraoperative Management

  • Be prepared to manage hypertension during surgery with:
    • Magnesium sulfate
    • Intravenous phentolamine (α-adrenoreceptor antagonist)
    • Calcium channel blockers
    • Nitroprusside or nitroglycerin 1, 2
  • Have esmolol (short-acting beta-blocker) available to treat tachycardia 2
  • Ensure adequate volume replacement to prevent hypotension 5, 7

Postoperative Care

  • Monitor for hypotension and treat aggressively if it occurs 1, 2
  • Monitor glucose levels carefully as hypoglycemia may occur after reduction of catecholamine levels 1, 2
  • Perform biochemical testing 2-8 weeks after surgery to confirm complete tumor resection 2, 8

Special Considerations

  • For patients with multifocal disease, prioritize resection of functional pheochromocytomas first 2
  • In patients with bilateral pheochromocytomas, consider cortical-sparing techniques versus total adrenalectomy based on hereditary risk factors 2
  • Laparoscopic approach is preferred for most pheochromocytomas, but open surgery should be considered for tumors >6 cm or with suspicion of malignancy 2

Common Pitfalls to Avoid

  • Starting beta-blockers before adequate alpha blockade (can precipitate hypertensive crisis) 1, 2, 4
  • Inadequate duration of preoperative alpha blockade (minimum 10-14 days needed) 1
  • Insufficient volume expansion before surgery (increases risk of postoperative hypotension) 2, 5
  • Failure to monitor for hypoglycemia postoperatively 1
  • Inadequate intraoperative monitoring of hemodynamic parameters 5, 6

The evidence strongly supports that proper preoperative alpha-adrenergic blockade significantly reduces perioperative morbidity and mortality in patients with pheochromocytoma undergoing surgical resection 1, 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Operative Management of Bilateral Pheochromocytoma

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Case report: pheochromocytoma. Aspects of management.

Anaesthesia and intensive care, 1976

Research

Metyrosine and pheochromocytoma.

Archives of internal medicine, 1997

Guideline

Pheochromocytoma Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.